Richard Lehman, John S Yudkin, Harlan Krumholz. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Cardiovascular Diseases/chemically inducedDiabetes Mellitus, Type 2/drug therapyDrug ApprovalHumansHypoglycemic Agents/adverse effectsHypoglycemic Agents/supply & distributionRosiglitazoneSafety-Based Drug WithdrawalsThiazolidinediones/adverse effectsThiazolidinediones/supply & distribution
Substances: See more » Hypoglycemic AgentsThiazolidinedionesRosiglitazone
Year: 2010 PMID: 20819887 DOI: 10.1136/bmj.c4805
Source DB: PubMed Journal: BMJ ISSN: 0959-8138